Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (2): 298-307.doi: 10.13481/j.1671-587X.20230205
• Research in basic medicine • Previous Articles Next Articles
Yunpeng LIU1,Zihao LIU1,Boming KANG2,Zhiguang YANG1(
)
Received:2022-06-27
Online:2023-03-28
Published:2023-04-24
Contact:
Zhiguang YANG
E-mail:zgyang@jlu.edu.cn
CLC Number:
Yunpeng LIU,Zihao LIU,Boming KANG,Zhiguang YANG. Regulatory effect of lncRNA SNHG17 on biological behavior of non-small cell lung cancer cells by targeting AEG1 through miR-384[J].Journal of Jilin University(Medicine Edition), 2023, 49(2): 298-307.
Tab. 1
Expression levels of lncRNA SNHG17, cell viabilities and numbers of migration and invasion cells in various groups after silencing lncRNA SNHG17 or over-expression of lncRNA SNHG17"
| Group | lncRNA SNHG17 | Cell viability (η/%) | Number of migration cells | Number of invasion cells |
|---|---|---|---|---|
| si-NC (A549 cells) | 1.03±0.24 | 95.32±5.45 | 384.00±12.00 | 191.00±5.03 |
| si-SNHG17 (A549 cells) | 0.21±0.02* | 45.68±10.22* | 289.00±6.08* | 111.00±3.06* |
| pcDNA3.1-NC (H1299 cells) | 1.02±0.19 | 96.56±3.89 | 499.00±13.53 | 147.00±6.11 |
| pcDNA3.1-SNHG17 (H1299 cells) | 6.35±1.42△ | 136.23±10.93△ | 716.00±11.27△ | 271.00±7.21△ |
Tab. 2
Expression levels of miR-384 and AEG1 mRNA in cells in various groups after silencing lncRNA SNHG17 or over-expression of lncRNA SNHG17"
| Group | miR-384 | AEG1 mRNA |
|---|---|---|
| si-NC(A549 cells) | 1.01±0.10 | 1.03±0.24 |
| si-SNHG17(A549 cells) | 1.46±0.20* | 0.06±0.02* |
| pcDNA3.1-NC(H1299 cells) | 1.01±0.13 | 1.02±0.19 |
| pcDNA3.1-SNHG17(H1299 cells) | 0.64±0.14△ | 2.34±0.27△ |
Tab. 3
Expression levels of miR-384, cell viabilities, numbers of migration and invasion cells in various groups"
| Group | miR-384 | Cell viability (η/%) | Number of migration cells | Number of invasion cells |
|---|---|---|---|---|
| Inhibitor NC(A549 cells) | 1.02±0.21 | 97.16±4.22 | 417.00±11.14 | 160.00±7.00 |
| miR-384 inhibitor(A549 cells) | 0.02±0.01* | 145.69±22.24* | 489.00±16.64* | 243.00±3.79* |
| Mimics NC(H1299 cells) | 1.02±0.21 | 96.37±3.22 | 518.00±11.53 | 207.00±6.03 |
| miR-384 mimics(H1299 cells) | 4.68±1.00△ | 65.67±6.40△ | 406.00±17.67△ | 116.00±8.00△ |
Tab. 4
Cell viabilities and numbers of migration and invasion cells in various groups after inhibiting or enhancing lncRNA SNHG17 and miR-384"
| Group | Cell viability (η/%) | Number of migration cells | Number ofinvasion cells | Expression level of AEG1 protein |
|---|---|---|---|---|
| si-NC+inhibitor NC(A549 cells) | 98.07±4.84 | 364.00±18.15 | 195.00±9.85 | 1.00±0.03 |
| si-SNHG17+inhibitor NC(A549 cells) | 63.26±6.04* | 314.00±8.72* | 108.00±6.11* | 0.72±0.01* |
| si-SNHG17+miR-384 inhibitor(A549 cells) | 78.69±6.65△ | 350.00±8.74△ | 199.00±11.15△ | 0.81±0.01△ |
| pcDNA3.1-NC+mimics NC(H1299 cells) | 101.26±5.91 | 496.00±18.23 | 148.00±4.58 | 1.00±0.02 |
| pcDNA3.1-SNHG17+mimics NC(H1299 cells) | 138.61±9.05# | 674.00±6.93# | 271.00±9.07# | 2.26±0.04# |
| pcDNA3.1-SNHG17+miR-384 mimics(H1299 cells) | 108.64±7.87○ | 582.00±14.53○ | 221.00±3.79○ | 1.56±0.02○ |
Tab. 5
Expression levels of AEG1 mRNA in cells, cell viabilities and numbers of migration and invasion cells in various groups after inhibiting or enhancing AEG1"
| Group | AEG1 mRNA | Cell viability (η/%) | Number of migration cells | Number of invasion cells |
|---|---|---|---|---|
| si-NC(A549 cells) | 1.02±0.22 | 98.67±4.76 | 381.00±13.08 | 167.00±6.03 |
| si-AEG1(A549 cells) | 0.56±0.08* | 71.32±8.98* | 308.00±10.26* | 115.00±10.02* |
| pcDNA3.1-NC(H1299 cells) | 1.01±0.11 | 99.21±7.66 | 499.00±11.53 | 137.00±7.09 |
| pcDNA3.1-AEG1(H1299 cells) | 3.15±0.90△ | 132.32±9.33△ | 609.00±11.14△ | 282.00±3.79△ |
Tab. 6
Cell viabilities and numbers of migration and invasion cells in various groups after inhibiting or enhancing miR-384 and AEG1 mRNA"
| Group | Cell viability (η/%) | Number of migration cells | Number of invasion cells |
|---|---|---|---|
| Inhibitor NC+si-NC(A549 cells) | 101.36±7.40 | 408.00±12.58 | 161.00±6.11 |
| miR-384 inhibitor+si-NC(A549 cells) | 145.37±19.97* | 481.00±8.66* | 256.00±9.17* |
| miR-384 inhibitor+si-AEG1(A549 cells) | 112.36±7.47△ | 425.00±9.07△ | 172.00±9.07△ |
| Mimics NC+pcDNA3.1-NC(H1299 cells) | 98.63±8.83 | 520.00±8.14 | 162.00±6.03 |
| miR-384 mimics+pcDNA3.1-NC(H1299 cells) | 63.17±9.12# | 401.00±10.44# | 117.00±2.08# |
| miR-384 mimics+pcDNA3.1-AEG1(H1299 cells) | 81.06±5.75○ | 589.00±6.24○ | 142.00±8.71○ |
| 1 | BALATA H, FONG K M, HENDRIKS L E, et al. Prevention and early detection for NSCLC: advances in thoracic oncology 2018 [J].J Thorac Oncol,2019,14(9): 1513-1527. |
| 2 | SUN J, ZHANG Z C, BAO S Q, et al. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer [J]. J Immunother Cancer, 2020, 8(1):e000110. |
| 3 | LI X Y, LI Y, YU X M, et al. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer [J]. J Transl Med, 2020, 18(1): 331. |
| 4 | LUO Y H, ZHENG S T, WU Q Y, et al. Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation [J]. Autophagy, 2021, 17(12): 4083-4101. |
| 5 | GHAFOURI-FARD S, SHOOREI H, BRANICKI W, et al. Non-coding RNA profile in lung cancer [J]. Exp Mol Pathol, 2020, 114: 104411. |
| 6 | WANG H B, MENG Q H, QIAN J J, et al. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer [J]. Pharmacol Ther, 2022, 234: 108123. |
| 7 | MA L, GAO J, ZHANG N, et al. Long noncoding RNA SNHG17: a novel molecule in human cancers [J]. Cancer Cell Int, 2022, 22(1): 104. |
| 8 | MA Z H, GU S Y, SONG M, et al. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer [J]. Mol Biosyst,2017,13(11): 2350-2361. |
| 9 | XU T W, YAN S, JIANG L H, et al. Gene Amplification-driven long noncoding RNA SNHG17 regulates cell proliferation and migration in human non-small-cell lung cancer [J]. Mol Ther Nucleic Acids, 2019, 17: 405-413. |
| 10 | MA T, ZHOU X J, WEI H L, et al. Long Non-coding RNA SNHG17 upregulates RFX1 by sponging miR-3180-3p and promotes cellular function in hepatocellular carcinoma [J]. Front Genet, 2020, 11: 607636. |
| 11 | ZHANG Y T, YANG G Y. LncRNA SNHG17 acts as a ceRNA of miR-324-3p to contribute the progression of osteosarcoma [J]. J Biol Regul Homeost Agents, 2020, 34(4): 1529-1533. |
| 12 | RELLI V, TREROTOLA M, GUERRA E, et al. Abandoning the notion of non-small cell lung cancer [J]. Trends Mol Med, 2019, 25(7): 585-594. |
| 13 | WANG M N, HERBST R S, BOSHOFF C. Toward personalized treatment approaches for non-small-cell lung cancer [J]. Nat Med, 2021, 27(8): 1345-1356. |
| 14 | WANG R Q, LONG X R, ZHOU N N, et al. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging miR-26a-5p to activate PTEN signaling in non-small cell lung cancer [J]. J Exp Clin Cancer Res, 2021, 40(1): 9. |
| 15 | TONG F, GUO J, MIAO Z Q, et al. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis [J]. Cancer Biomark, 2021, 30(1): 1-12. |
| 16 | CHEN W H, WANG L F, LI X Y, et al. LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma [J]. Cell Death Dis, 2021, 12(9): 806. |
| 17 | ZHANG Z W, YAN Y L, ZHANG B, et al. Long non-coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA-193a-5p/NETO2 axis [J]. Oncol Lett, 2021, 22(6): 818. |
| 18 | LI W, ZHENG Y Q, MAO B, et al. SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p[J]. Biochem Biophys Res Commun, 2020, 533(4): 1435-1441. |
| 19 | FAN N, ZHANG J, CHENG C T, et al. MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling [J]. Biomed Pharmacother, 2017, 95: 1331-1337. |
| 20 | ZHONG B Z, WANG Q, LIU F, et al. Effects of miR-384 and miR-134-5p acting on YY1 signaling transduction on biological function of gastric cancer cells [J]. Onco Targets Ther, 2020, 13: 9631-9641. |
| 21 | TIAN Y H, JIA L W, LIU Z F, et al. LINC01087 inhibits glioma cell proliferation and migration, and increases cell apoptosis via miR-384/Bcl-2 axis [J]. Aging (Albany NY), 2021, 13(16): 20808-20819. |
| 22 | SUN H, CHEN Y, FANG Y Y, et al. Circ_0000376 enhances the proliferation, metastasis, and chemoresistance of NSCLC cells via repressing miR-384 [J]. Cancer Biomark, 2020, 29(4): 463-473. |
| 23 | GUO Q K, ZHENG M, XU Y, et al. MiR-384 induces apoptosis and autophagy of non-small cell lung cancer cells through the negative regulation of Collagen α-1(X) chain gene [J]. Biosci Rep, 2019,39(2):BSR20181523. |
| 24 | LI Y H, XU C L, HE C J, et al. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC [J]. Mol Carcinog,2020,59(2): 141-153. |
| 25 | SRIRAMULU S, SUN X F, MALAYAPERUMAL S, et al. Emerging role and clinicopathological significance of AEG-1 in different cancer types: a concise review [J]. Cells, 2021, 10(6):1497. |
| [1] | Yu ZHAO,Xiaoshuang HE,Xiaoyin DONG,Fengyi GAO,Jiageng HE. Regulatory effect of lncRNA urothelial carcinoembryonic antigen 1 on anoikis in human gastrointestinal stromal tumor cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 429-439. |
| [2] | Wenxuan LI,Minru ZONG. Research progress in role of migration of Schwann cells in repairment of peripheral nerve injury [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1137-1144. |
| [3] | Xiaoshuang HE,Lina XU,Mei CUI,Yu ZHAO,Bei WANG,Zheng HUANG,Yuchao WANG,Wenyan XIN,Chao WU. Effects of lncRNA DUXAP8 in lung cancer A549 cells-derived exosomes on lung cancer cell growth and its mechnism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 958-967. |
| [4] | Yuan WANG,Zhijuan WANG,Mingshu ZHANG,Yihui WANG,Qing ZHANG,Liping YE. Effects of monocyte chemoattractant protein-1 on invasion and migration of lung cancer A549 and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 666-675. |
| [5] | Aihua REN,Yanbo DONG,Runzhi MIAO,Yujiao LYU,Yanfeng LIU. Effect of ganoderic acid A on glycolysis and its key rate-limiting enzymes of non-small cell lung cancer PC9 cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 682-688. |
| [6] | Zongjun CHEN,Yahong CHEN,Liyun HUANG,Ziying LIANG. Effects of genomic instability and MYC gene mutation of non-small cell lung cancer A549 cells on resistance of gemcitabine [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 355-363. |
| [7] | Zhongxin FENG,Mei LI. Effect of soluble CD40 ligand on biological behavior of THP-1 cells through long non-coding RNA linc00239 [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 88-96. |
| [8] | Ruipeng ZHANG,Jie LI. Resistance and regeneration effects of lncRNA GPRC5D-AS1 on muscle atrophy of myocytes in mice induced by dexamethasone and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1457-1465. |
| [9] | Na NI,Hongliang DONG,Haiyang GAO,Weiwei CHEN,Xinyu MENG,Bingjie CUI,Jing DU. Construction of human lncRNA-GACAT2 over-expression vector and its effect on proliferation and stemness of lung cancer cells [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1147-1153. |
| [10] | Chang GAO,Yan LIU,Haoxiang YANG,Cuicui ZHANG. Effect of long non-coding RNA MALAT1 on angiogenesis of human brain microvascular endothelial cells induced by oxygen-glucose deprivation/reoxygenation hypoxic [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 832-839. |
| [11] | Shengyu YAN,Changhua LIU,Zhijie XU,Yating DING,Yafeng XIE,Qiao ZHANG,Wanying LIU. Effect of lncRNA PAX8-AS1 on proliferation, apoptosis and invasion of colorectal cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 656-664. |
| [12] | Bo HUANG,Jie DING,Hongrong GUO,Hongjuan WANG,Jianqun XU,Quan ZHENG. Effects of HIF-1α/ROS on apoptosis and invasion of lung cancer A549 cells under hypoxia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 682-690. |
| [13] | Lingyao XU,Shutang WEI,Yong DONG,Zhenglu SUN,Junbo ZHAO,Dazheng HAN. Regulatory effect of lncRNA MALAT1 on activation of hepatic stellate cell and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 697-705. |
| [14] | Hui MIAO,Congxiu MIAO,Na LI,Jing HAN. Inhibitory effect of lncRNA HAND2-AS1 on migration and invasion of endometrial stromal cells in patients with endometriosis by regulating expression of miR-21 [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 733-741. |
| [15] | Wenli JIANG,Lin ZHANG,Junyao LI,Mingyu XU,Jie ZHANG,Chunling DONG. Targeted therapy of osimertinib combined with savolitinib in NSCLC with EGFR-TKI resistance complicated with MET amplification: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 782-788. |
|